SynthesisInternational journal of dermatology2025

Dupilumab for the Treatment of Cutaneous Immune-Related Adverse Events: A Systematic Review.

Ioannis-Alexios Koumprentziotis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.